Bile salt composition is secondary to bile salt concentration in determining hydrocortisone and progesterone solubility in intestinal mimetic fluids

被引:17
作者
Zughaid, Huda [1 ]
Forbes, Ben [1 ]
Martin, Gary P. [1 ]
Patel, Nilesh [1 ]
机构
[1] Kings Coll London, Inst Pharmaceut Sci, London SE1 9NH, England
关键词
Solubility; Simulated intestinal fluids; Hydrocortisone; Progesterone; Lecithin; Bile salts; DISSOLUTION MEDIA; LIPID FORMULATIONS; SOLUBLE DRUG; BEHAVIOR; DANAZOL; RELEASE;
D O I
10.1016/j.ijpharm.2011.11.012
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Simulated intestinal fluids (SIFs) used to assay the solubility of orally administered drugs are typically based on a single bile salt; sodium taurocholate (STC). The aim of this study was to develop mimetic intestinal fluids with a closer similarity to physiological fluids than those reported to date by developing a mixed bile salt (MBS) system (STC, sodium glycodeoxycholate, sodium deoxycholate; 60:39:1) with different concentrations of lecithin, the preponderant intestinal phospholipid. Hydrocortisone and progesterone were used as model drugs to evaluate systematically the influence of SIF composition on solubility. Increasing total bile salt concentration from 0 to 30 mM increased hydrocortisone and progesterone solubility by 2- and similar to 25-fold, respectively. Accordingly, higher solubilities were measured in the fed-state compared to the fasted-state SIFs. Progesterone showed the greatest increases in solubility in STC and MBS systems (2-7-fold) compared to hydrocortisone (no significant change; P>0.05) as lecithin concentration was increased. Overall, MBS systems gave similar solubility profiles to STC. In conclusion, the addenda of MBS and lecithin were found to be secondary to the influence of BS concentration. These data provide a foundation for the design of more bio-similar media for pivotal decision-guiding assays in drug development and quality control settings. (c) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:295 / 301
页数:7
相关论文
共 31 条
  • [1] A THEORETICAL BASIS FOR A BIOPHARMACEUTIC DRUG CLASSIFICATION - THE CORRELATION OF IN-VITRO DRUG PRODUCT DISSOLUTION AND IN-VIVO BIOAVAILABILITY
    AMIDON, GL
    LENNERNAS, H
    SHAH, VP
    CRISON, JR
    [J]. PHARMACEUTICAL RESEARCH, 1995, 12 (03) : 413 - 420
  • [2] High throughput UV method for the estimation of thermodynamic solubility and the determination of the solubility in biorelevant media
    Bard, Bruno
    Martel, Sophie
    Carrupt, Pierre-Alain
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2008, 33 (03) : 230 - 240
  • [3] Is bicarbonate buffer suitable as a dissolution medium?
    Boni, Julia Elisabeth
    Brickl, Rolf Stefan
    Dressman, Jennifer
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 2007, 59 (10) : 1375 - 1382
  • [4] Study of partition of nitrazepam in bile salt micelles and the role of lecithin
    de Castro, B
    Gameiro, P
    Guimaraes, C
    Lima, JLFC
    Reis, S
    [J]. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2001, 24 (04) : 595 - 602
  • [5] Characterization of fasted-state human intestinal fluids collected from duodenum and jejunum
    de la Cruz Moreno, Mariangeles Perez
    Oth, Marianne
    Deferme, Sven
    Lammert, Frank
    Tack, Jan
    Dressman, Jennifer
    Augustijns, Patrick
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 2006, 58 (08) : 1079 - 1089
  • [6] Estimating drug solubility in the gastrointestinal tract
    Dressman, J. B.
    Vertzoni, M.
    Goumas, K.
    Reppas, C.
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2007, 59 (07) : 591 - 602
  • [7] Dissolution testing as a prognostic tool for oral drug absorption: Immediate release dosage forms
    Dressman, JB
    Amidon, GL
    Reppas, C
    Shah, VP
    [J]. PHARMACEUTICAL RESEARCH, 1998, 15 (01) : 11 - 22
  • [8] Edmund K., 2002, PHARM RES, V19, P345
  • [9] Evaluation of various dissolution media for predicting in vivo performance of class I and II drugs
    Galia, E
    Nicolaides, E
    Hörter, D
    Löbenberg, R
    Reppas, C
    Dressman, JB
    [J]. PHARMACEUTICAL RESEARCH, 1998, 15 (05) : 698 - 705
  • [10] HEUMAN DM, 1989, J LIPID RES, V30, P719